131 related articles for article (PubMed ID: 16772830)
1. Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility.
Basu KK; Talwar V; de Caestecker JS
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):733-7. PubMed ID: 16772830
[TBL] [Abstract][Full Text] [Related]
2. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
3. The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
Globe J; Smythe A; Kelty CJ; Reed MW; Brown NJ; Ackroyd R
J Photochem Photobiol B; 2006 Oct; 85(1):17-22. PubMed ID: 16723253
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
Sharma P; Wani S; Weston AP; Bansal A; Hall M; Mathur S; Prasad A; Sampliner RE
Gut; 2006 Sep; 55(9):1233-9. PubMed ID: 16905695
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
6. The effect of argon plasma coagulation ablation on esophageal motility and chemoreceptor sensitivity in Barrett's esophagus patients.
Smythe A; Elghellal K; Kelty C; Mitton D; Patel K; Ackroyd R
Dis Esophagus; 2010 Aug; 23(6):445-50. PubMed ID: 20236298
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
[TBL] [Abstract][Full Text] [Related]
8. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
Smythe A; Troy GP; Ackroyd R; Bird NC
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results.
Bright T; Watson DI; Tam W; Game PA; Astill D; Ackroyd R; Wijnhoven BP; Devitt PG; Schoeman MN
Ann Surg; 2007 Dec; 246(6):1016-20. PubMed ID: 18043104
[TBL] [Abstract][Full Text] [Related]
11. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation.
Mörk H; Al-Taie O; Berlin F; Kraus MR; Scheurlen M
Scand J Gastroenterol; 2007 Jan; 42(1):23-7. PubMed ID: 17190758
[TBL] [Abstract][Full Text] [Related]
12. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Todd JA; Basu KK; de Caestecker JS
Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
[TBL] [Abstract][Full Text] [Related]
13. Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.
Manner H; May A; Miehlke S; Dertinger S; Wigginghaus B; Schimming W; Krämer W; Niemann G; Stolte M; Ell C
Am J Gastroenterol; 2006 Aug; 101(8):1762-9. PubMed ID: 16817835
[TBL] [Abstract][Full Text] [Related]
14. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.
El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE
Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506
[TBL] [Abstract][Full Text] [Related]
15. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
16. Relationship between pressure wave amplitude and esophageal bolus clearance assessed by combined manometry and multichannel intraluminal impedance measurement.
Nguyen NQ; Tippett M; Smout AJ; Holloway RH
Am J Gastroenterol; 2006 Nov; 101(11):2476-84. PubMed ID: 17029613
[TBL] [Abstract][Full Text] [Related]
17. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.
Ferraris R; Fracchia M; Foti M; Sidoli L; Taraglio S; Vigano' L; Giaccone C; Rebecchi F; Meineri G; Senore C; Pera A;
Aliment Pharmacol Ther; 2007 Apr; 25(7):835-40. PubMed ID: 17373922
[TBL] [Abstract][Full Text] [Related]
18. Thermal ablation of Barrett's esophagus: a heated debate.
Spechler SJ
Am J Gastroenterol; 2006 Aug; 101(8):1770-2. PubMed ID: 16928252
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy.
Manner H; May A; Rabenstein T; Pech O; Nachbar L; Enderle MD; Gossner L; Ell C
Scand J Gastroenterol; 2007 Mar; 42(3):397-405. PubMed ID: 17354121
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.
Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J
Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
